Skip to content

Genelux vs Prescient Therapeutics

Genelux logo

Genelux

34 employees · est. 2001 · Westlake Village, United Sta...

VS
Prescient Therapeutics logo

Prescient Therapeutics

A clinical stage oncology company developing personalised medicine approaches to cancer; cellular & targeted therapies

14 employees · est. 2014 · Australia

Genelux is the older company (2001 vs 2014).

Side-by-Side Comparison

Genelux Prescient Therapeutics
Founded
2001 older 2014
Headquarters
Westlake Village, United States Australia
Employees
34 14
Industry
Biopharma, Biotechnology, Health Care Biopharma, Biotechnology, Health Care
Funding Stage
Post-IPO Equity Post-IPO Equity
Total Funding
$98.98M $3.00M
Funding Rounds
5 1
Services
Development of oncolytic immunotherapy, Clinical trial management, Expanded access programs Not tracked yet
Target Customers
Cancer patients, Healthcare professionals, Clinical researchers Not tracked yet
Taxonomy
Oncolytic ImmunotherapySolid TumorsCancer TreatmentClinical-stage BiotechViral TherapyImmunotherapies +4 OncologyPersonalized MedicineCell TherapiesTargeted TherapiesImmunotherapyCancer Treatment +9
Website
genelux.com ptxtherapeutics.com
Genelux logo

About Genelux

Genelux Corporation (NASDAQ: GNLX) is a late clinical-stage biotechnology firm founded in 2001 and based in the United States. The company operates at the forefront of the Biopharma, Biotechnology, and Health Care industries, focusing on oncolytic immunotherapy to improve patient outcomes in cases o...

Prescient Therapeutics logo

About Prescient Therapeutics

Prescient Therapeutics is a clinical stage oncology company with a focus on developing personalized medicine approaches for cancer treatment. The company is involved in the development of both targeted and cellular therapies. One of their prominent technologies is OmniCAR, a universal immune recept...

Also comparing in this category

Comparing more than these two?

Get Genelux, Prescient Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Genelux compare?

A PDF of Genelux and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Genelux was founded in 2001, based in Westlake Village, United States, with 34 employees. Genelux Corporation (NASDAQ: GNLX) is a late clinical-stage biotechnology firm founded in 2001 and based in the United States. The company operates at the forefront of the Biopharma, Biotechnology, an. Prescient Therapeutics was founded in 2014, based in Australia, with 14 employees. Prescient Therapeutics is a clinical stage oncology company with a focus on developing personalized medicine approaches for cancer treatment. The company is involved in the development of both targete.
Genelux has raised $98.98M and Prescient Therapeutics $3.00M. Latest stage: Genelux Post-IPO Equity, Prescient Therapeutics Post-IPO Equity.
Both work in Biopharma, Biotechnology and Health Care and list solid tumors, cancer treatment and clinical trials among their focus areas.

Compare Genelux with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Genelux on 2 Apr 2026, and Prescient Therapeutics on 6 Dec 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout